Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with... see more

Bullboard (NYSE:GSK)

View:
Post by whytestockson Aug 06, 2024 11:30pm

Myriad Genetics Reports Strong Second Quarter 2024 Financial

News; $GSK Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12 ...more  
63
Post by Thundeon Jun 09, 2022 10:26am

Great News !!!! this would be amazing !!

https://www.washingtonpost.com/health/2022/06/08/cancer-drug-trial/ https://nationalpost.com/health/small-cancer-drug-trial-sees-tumours-disappear-in-100-per-cent-of-patients
212
Post by Rainbowflieron May 04, 2022 5:40pm

Glaxo

Doesn't sell the cure Glaxo Sells the disease
216
Post by CBalardoon Oct 20, 2021 5:14am

5% divided with huge upside with split

This company will be more profitable once they split up work it as two companies. Their pipeline of drugs and monoclonal antibody authorization is going help out this year. How they can suppress a ...more  
279
Post by Mil_Man54on Dec 26, 2020 8:12am

Bonvoyage12....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on multiple boards
250
Post by IamMagicon Dec 01, 2020 3:58am

Why is it so low

I don't understand why this stock is even lower than before the pandemic. They have the potential to enter in the Covid vaccine market early 2021 with the partnership with Medicago. Medicago ...more  
701
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities